Koyfin Home > Directory > Health Care > Acceleron Pharma > Issuance of Common Stock

Acceleron Pharma Issuance of Common Stock Chart (XLRN)

Acceleron Pharma annual/quarterly Issuance of Common Stock from 2012 to 2020.
  • Acceleron Pharma Issuance of Common Stock for the quarter ending June 06, 2020 was $19m a 73.63% increase of 14m year over year
  • Acceleron Pharma Issuance of Common Stock for the last 12 months ending June 06, 2020 was $36m a -610.16% decrease of -221m year over year
  • Acceleron Pharma Annual Issuance of Common Stock for 2019 was $260m a 93.44% increase of 243m from 2018
  • Acceleron Pharma Annual Issuance of Common Stock for 2018 was $17m a -1,195.97% decrease of -204m from 2017
  • Acceleron Pharma Annual Issuance of Common Stock for 2017 was $221m a 33.49% increase of 74m from 2016
Other Cash Flow Metrics:
  • Acceleron Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-29m a 19.28% decrease of -6m year over year
  • Acceleron Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-41m a 62.43% decrease of -26m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Issuance of Common Stock Data

06/2020$19m
03/2020$9m
12/2019$3m
09/2019$5m
06/2019$2m
03/2019$249m
12/2018$2m
09/2018$8m
06/2018$2m
03/2018$5m

Annual XLRN Issuance of Common Stock Data

2019$260m
2018$17m
2017$221m
2016$147m
2015$5m
2014$133m
2013$97m
2012$0m
2011$0m